Wells Fargo Reiterates Equal Weight Rating on Travere Therapeutics (TVTX)
Tweet Send to a Friend
Wells Fargo analyst Mohit Bansal reiterated an Equal Weight rating and $9.00 price target on Travere Therapeutics (NASDAQ: TVTX).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
